Overview

Pharmacokinetics, Safety, and Tolerability of rhEGF Eye Drops in Healthy Male Subjects

Status:
Completed
Trial end date:
2019-11-13
Target enrollment:
Participant gender:
Summary
A randomized, double-blind, placebo-controlled, single ascending dose and multiple ascending dose study of the Pharmacokinetics, safety, and tolerability of rhEGF eye drops in healthy male subjects
Phase:
Phase 1
Details
Lead Sponsor:
Daewoong Bio Inc.